← Back to Clinical Trials
Recruiting NCT07201220

NCT07201220 Meditation in Early Labor: Impact on Self-Efficacy and Childbirth Fear in First-Time Mothers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07201220
Status Recruiting
Phase —
Sponsor Seyhan District Health Directorate, Adana
Condition Meditation
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-07-01
Primary Completion 2025-09-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
meditation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-07-01 with a primary completion date of 2025-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Aim-Introduction: The feeling of uncertainty about what will happen during labor, and the mother's perception of inadequacy regarding childbirth, can lead to anxiety and stress in some pregnant women, resulting in fear of childbirth and avoidance behaviors. This study was conducted to examine whether there are significant differences in childbirth self-efficacy and fear of childbirth between primiparous pregnant women who practiced meditation and those who did not during the first stage of labor. Materials and Methods: This experimental study is planned to be conducted between 01.04.2025 and 01.08.2025 with a total of 60 pregnant women (30 in the experimental group and 30 in the control group) who applied to the delivery unit of a tertiary hospital in Turkey and were in the first stage of labor. After informing the pregnant women about the study and the procedures to be implemented, written informed consent was obtained from those who agreed to participate. Subsequently, the pre-tests of the relevant scales and the data collection form were administered. The relaxation meditation during childbirth was applied to the experimental group, followed by the post-tests of the same scales. Data were collected using the "Childbirth Self-Efficacy Inventory Short Form" and the "Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ) Version A." Descriptive statistics and hypothesis tests will be used for data analysis.

Eligibility Criteria

Inclusion Criteria: Primiparous pregnant women In the first stage of labor Singleton pregnancy Aged 18 and above Able to provide informed consent No high-risk pregnancy or psychiatric diagnosis Exclusion Criteria: Multiparous women High-risk pregnancy Previous experience with meditation during labor Communication difficulties

Frequently Asked Questions

Who can join the NCT07201220 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Meditation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07201220 currently recruiting?

Yes, NCT07201220 is actively recruiting participants. Visit ClinicalTrials.gov or contact Seyhan District Health Directorate, Adana to inquire about joining.

Where is the NCT07201220 trial being conducted?

This trial is being conducted at Adana, Turkey (Türkiye), Seyhan, Turkey (Türkiye).

Who is sponsoring the NCT07201220 clinical trial?

NCT07201220 is sponsored by Seyhan District Health Directorate, Adana. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology